Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Structure Therapeutics Inc. - American Depositary Shares (NQ:GPCR)

36.82 +1.82 (+5.20%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,808,707
Open	35.00
Bid (Size)	36.96 (100)
Ask (Size)	37.75 (100)
Prev. Close	35.00
Today's Range	34.82 - 37.60
52wk Range	13.22 - 37.76
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 07, 2025

Via Benzinga

Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

November 06, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Performance

YTD	+30.6%	+30.6%
1 Month	+33.6%	+33.6%
3 Month	+84.5%	+84.5%
6 Month	+47.3%	+47.3%
1 Year	+7.8%	+7.8%

More News

This Under-the-Radar Healthcare Stock Could Soar in 2026 ↗

September 12, 2025

Via The Motley Fool

Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences

September 02, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform

August 18, 2025

Via AB Newswire

Eli Lilly Stock Marks Worst Day In 25 Years As Weight-Loss Pill Data Disappoints: Analysts Divided But Retail Bets On Rebound ↗

August 07, 2025

Via Stocktwits

Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations

August 07, 2025

Via MarketMinute

Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors ↗

August 07, 2025

Via Benzinga

Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge. ↗

August 07, 2025

Via Investor's Business Daily

Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

August 06, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671

June 20, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

May 29, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights

May 08, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

There are notable gap-ups and gap-downs in today's session. ↗

April 17, 2025

Via Chartmill

uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday ↗

April 17, 2025

Via Benzinga

Wall Street Sees Pfizer's Weight-Loss Pill Exit As A Win For 2 Smaller Biotech Firms: Retail Turns Bullish ↗

April 15, 2025

Via Stocktwits

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today ↗

April 14, 2025

Via The Motley Fool

What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday? ↗

April 14, 2025

Via Benzinga

The State of Weight Loss Drugs ↗

March 10, 2025

Via The Motley Fool

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion. ↗

March 03, 2025

Via Investor's Business Daily

Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights

February 27, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

Why Structure Therapeutics Stock Was Stumbling This Week ↗

February 14, 2025

Via The Motley Fool

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

January 30, 2025

From Structure Therapeutics Inc.

Via GlobeNewswire

AI Pharma: 2 Paths to AI-Powered Drug Investment

January 28, 2025

Via MarketBeat

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. ↗

January 09, 2025

Via Investor's Business Daily

Frequently Asked Questions

Is Structure Therapeutics Inc. - American Depositary Shares publicly traded?

Yes, Structure Therapeutics Inc. - American Depositary Shares is publicly traded.

What exchange does Structure Therapeutics Inc. - American Depositary Shares trade on?

Structure Therapeutics Inc. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Structure Therapeutics Inc. - American Depositary Shares?

The ticker symbol for Structure Therapeutics Inc. - American Depositary Shares is GPCR on the Nasdaq Stock Market

What is the current price of Structure Therapeutics Inc. - American Depositary Shares?

The current price of Structure Therapeutics Inc. - American Depositary Shares is 36.82

When was Structure Therapeutics Inc. - American Depositary Shares last traded?

The last trade of Structure Therapeutics Inc. - American Depositary Shares was at 11/14/25 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.